Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#caffeine citrate ×

Regulatory Updates

Aug 30, 2026•1 min read

FDA Approves ANDA077997 for Caffeine Citrate Intravenous Solution

The FDA has granted approval for ANDA077997, an intravenous caffeine citrate solution manufactured by Fresenius Kabi USA, now listed as a prescription drug.